Journal of clinical sleep medicine : JCSM : official publication of the American Academy of Sleep Medicine

Guidelines for Treating Natural Sleep-Wake Cycle Disorders: Early, Delayed, Non-24-Hour, and Irregular Sleep Patterns

Updated

Abstract

Strategically timed melatonin is positively endorsed for treating intrinsic circadian rhythm sleep-wake disorders in select populations.

  • Melatonin is recommended for adults with delayed sleep-wake phase disorder (DSWPD), blind adults with non-24-hour sleep-wake disorder (N24SWD), and children/adolescents with irregular sleep-wake rhythm disorder (ISWRD) and neurological comorbidities.
  • Light therapy, with or without behavioral interventions, is suggested for adults with advanced sleep-wake phase disorder (ASWPD), children/adolescents with DSWPD, and elderly individuals with dementia.
  • Recommendations against melatonin use are made for elderly patients with dementia, supported by a first-tier degree of confidence.
  • No recommendations were given for other treatments due to insufficient or absent data, highlighting gaps in current research.

Simplified

Full Text

Full text is available at the source.

what lands in your inbox each week:

  • 📚7 fresh studies
  • 📝plain-language summaries
  • direct links to original studies
  • 🏅top journal indicators
  • 📅weekly delivery
  • 🧘‍♂️always free